AAV Craniotomy

By Santiago Unda, MD, Roberta Marongiu, PhD, Mihaela Stavarache and Michael Kaplitt, MD, PhD
View Published Protocol

Output Details

Description
This protocol is for injection of AAV into a mouse brain using a stereotactic frame and Hamilton syringe.
Identifier (DOI)
10.17504/protocols.io.5jyl829q7l2w/v1
Tags
  • AAV (Adenoassociated Virus)
  • Animal
  • In Vivo
  • Mouse
  • Stereotactic
  • Surgical
Team
Team Kaplitt
Program
Collaborative Research Network
Theme
Circuitry and Brain-Body Interactions

Meet the Authors

Related Research

Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficits

Study shows increasing PGK1 gene expression enhances neuronal ATP production, protecting against synaptic dysfunction in Parkinson's disease. Boosting bioenergetics with PGK1 may be a promising therapeutic approach for PD.

View Article

Protocol for CRISPR-based manipulation and visualization of endogenous α-synuclein in cultured mouse hippocampal neurons

Protocol for depleting or tagging endogenous α-syn using virally-delivered CRISPR-Cas9 in hippocampal neurons

View Protocol

pAAV-pCAG-Floxed-SynGFP,rev.-WPRE (e.g. AAV-flex-SynTag)

CAG-driven, Cre-dependent synaptophysin-tagged GFP for anterograde tracing of neuronal projections.

View Lab Material
View More Outputs
Aligning Science Across Parkinson's
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.